From April 1, 2023 to June 30, 2023, the company has repurchased 2,028,311 shares, representing 0.73% for $5.79 million. With this, the company has completed the repurchase of 13,106,234 shares, representing 4.64% for $33.49 million under the buyback announced on May 5, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
226 GBX | -1.09% | +1.57% | +16.37% |
03:08pm | PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug | AN |
May. 20 | PureTech Health Opens $100 Million Buyback Program | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.37% | 786M | |
+42.29% | 54.04B | |
+43.57% | 41.96B | |
-1.39% | 41.92B | |
-7.59% | 28.35B | |
+11.63% | 26.35B | |
-22.24% | 19B | |
+7.83% | 13B | |
+28.42% | 12.28B | |
+25.69% | 12.19B |
- Stock Market
- Equities
- PRTC Stock
- News PureTech Health plc
- Tranche Update on PureTech Health plc's Equity Buyback Plan announced on May 5, 2022.